🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multicenter, single-arm, two-stage, Phase Ib study d...
Status
Completed
Location
University Of Colorado
Start Date
2016-09-30
Trial ID
NCT02876224
Treatments Being Tested
The goal of this clinical trial is to learn if the drug toripalimab (an ant...
Status
Active Not Recruiting
Location
Changyi Quan
Start Date
2022-10-10
Trial ID
NCT06584435
Treatments Being Tested
This is an open-label Phase 1/2a study. Once the safety of the BC1 cell lin...
Status
Recruiting
Location
Sarcoma Oncology Center
Start Date
2024-05-29
Trial ID
NCT06471673
The purpose of this study is to evaluate the efficacy and safety of novel p...
Status
Completed
Location
National Cancer Center
Start Date
2015-04
Trial ID
NCT02418689
Treatments Being Tested
This phase I/II trial evaluates the highest safe dose, side effects, and po...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2021-11-08
Trial ID
NCT04851119
Treatments Being Tested
Recombinant oncolytic adenovirus injection (KD01) is an oncolytic virus pro...
Status
Recruiting
Location
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Start Date
2024-11-04
Trial ID
NCT07359235
Treatments Being Tested
The objective of this trial is to compare the bioavailability (AUC, Tmax, a...
Status
Completed
Location
ISURA
Start Date
2022-03-01
Trial ID
NCT06151171
Treatments Being Tested
This is a Phase 1, open-label, dose-escalation and expansion study evaluati...
Status
Terminated
Location
Exelixis Clinical Site #4
Start Date
2021-02-10
Trial ID
NCT04726332
Treatments Being Tested
This study is designed to assess the efficacy and safety of ifinatamab deru...
Status
Recruiting
Location
Valkyrie Clinical Trials
Start Date
2024-04-10
Trial ID
NCT06330064
Treatments Being Tested
Cabazitaxel is a new taxoid which promotes the tubulin assembly in vitro an...
Status
Completed
Location
Luisenkrankenhaus
Start Date
2013-02
Trial ID
NCT01779479
Treatments Being Tested